Sort
59,101 grants matching “hypertension”
RGS Protein Function and Regulation
$490,157Kendall Jay Blumer · Washington University · R01 · FY2009 · HL
PATHWAY AND EXCEPTIONAL LONGEVITY
$490,141Nir J Barzilai · Albert Einstein College Of Medicine · P01 · FY2011 · AG
SECONDARY PREVENTION IN SMALL SUBCORTICAL STROKES (SPS3)
$490,136University Of Texas Hlth Sci Ctr San Ant · R01 · FY2000 · NS
Pathobiology of Occlusive Vascular Disease
$490,113Jean Chrisostome Bopassa · University Of Texas Hlth Science Center · T32 · FY2025 · HL
Identification of Prediabetes Genes by Expression Linkage Analysis
$490,093Christopher P Jenkinson · University Of Texas Hlth Science Center · R01 · FY2012 · DK
Comprehensive Approach for Hypertension Prevention and Control in Argentina
$490,061Jiang He · Tulane University Of Louisiana · U01 · FY2013 · HL
Extending the Ischemic Penumbra in Large Vessel Occlusion Stroke
$490,049Edwin M Nemoto · Shearit, Llc · R41 · FY2024 · NS
Myocardial Fibrosis in Hypertensive Adults with and without Chronic Kidney Disease
$490,024Mirela Aurora Dobre · Case Western Reserve University · R01 · FY2018 · HL
Immune Cells and Hypertension
$490,009David L. Mattson · Medical College Of Wisconsin · P01 · FY2020 · HL
A Digital Hemodynamic Twin for Right Ventricular Dysfunction
$490,001Nicholas E. Houstis · Massachusetts General Hospital · R01 · FY2025 · HL
ALDH1a1 Inhibition As A Therapeutic Target In Visceral Adiposity and Type 2 Diabetes
$490,000Jorge Plutzky · Brigham And Women'S Hospital · R01 · FY2017 · DK
Cell-cell Interactions in the Retinal Vasculature
$490,000Patricia Ann D'amore · Schepens Eye Research Institute · R01 · FY2006 · EY
ALDH1a1 Inhibition As A Therapeutic Target In Visceral Adiposity and Type 2 Diabetes
$490,000Jorge Plutzky · Brigham And Women'S Hospital · R01 · FY2021 · DK
ALDH1a1 Inhibition As A Therapeutic Target In Visceral Adiposity and Type 2 Diabetes
$490,000Jorge Plutzky · Brigham And Women'S Hospital · R01 · FY2019 · DK
ALDH1a1 Inhibition As A Therapeutic Target In Visceral Adiposity and Type 2 Diabetes
$490,000Jorge Plutzky · Brigham And Women'S Hospital · R01 · FY2020 · DK
Automated Assessment of Leptomeningeal Collaterals on CT Angiograms
$489,999Yueh Z Lee · Kitware, Inc. · R42 · FY2018 · NS
Forebrain-hypothalamic mechanisms in obesity-induced hypertension
$489,986Colin Neal Young · George Washington University · R01 · FY2018 · HL
Forebrain-hypothalamic mechanisms in obesity-induced hypertension
$489,986Colin Neal Young · George Washington University · R01 · FY2019 · HL
Energetic State and Metabolic Remodeling in Cardiac Hypertrophy and Failure
$489,968Qinglin Yang · Lsu Health Sciences Center · R01 · FY2023 · HL
Randomized Trial of Stepped Palliative Care versus Early Integrated Palliative Care in Patients with Advanced Lung Cancer
$489,932Jennifer Temel · Massachusetts General Hospital · R01 · FY2019 · CA
Progression of Acute Kidney Injury to Chonic Kidney Disease
$489,853Chirag R Parikh · Yale University · U01 · FY2010 · DK
Cardiovascular Peptides and Myocardial Infarction
$489,841John C Burnett · Mayo Clinic Rochester · R01 · FY2008 · HL
Long-term effects of acute renal failure
$489,836David P. Basile · Indiana University Indianapolis · R01 · FY2020 · DK
Long-term effects of acute renal failure
$489,836David P. Basile · Indiana University Indianapolis · R01 · FY2021 · DK
Long-term effects of acute renal failure
$489,836David P. Basile · Indiana University Indianapolis · R01 · FY2019 · DK